{"id":"W4283120210","doi":"10.1016/j.anai.2022.06.012","title":"Biologic use and outcomes among adults with severe asthma treated by US subspecialists","year":2022,"lang":"en","type":"article","venue":"Annals of Allergy Asthma & Immunology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Omalizumab; Mepolizumab; Benralizumab; Exacerbation; Asthma; Cohort; Dupilumab; Internal medicine; Asthma exacerbations; Pediatrics; Immunology; Immunoglobulin E; Antibody; Eosinophil","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003574893,0.0002107188,0.0003017385,0.0005667247,0.0003737196,0.000837013,0.0002677405,0.0007836508,0.002172133],"category_scores_gemma":[0.001991679,0.00018321,0.0008989521,0.0008284082,0.0001853867,0.0005504962,0.0004929926,0.001144533,0.0002186653],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004648183,"about_ca_system_score_gemma":0.0005006939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01464092,"about_ca_topic_score_gemma":0.01863441,"domain_scores_codex":[0.999571,0.00007693164,0.00005649956,0.00006890309,0.00008372293,0.0001428262],"domain_scores_gemma":[0.9985167,0.0001966185,0.0008200635,0.00006096712,0.0001018542,0.0003037506],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001467686,0.0000714043,0.9984812,0.00001018309,0.00009713912,0.00004386088,0.00002773181,0.00002967179,0.00005291112,0.00001723279,0.0001830476,0.0008387607],"study_design_scores_gemma":[0.0000142844,0.00009224915,0.9992309,0.00001214095,0.00005104349,0.00009324146,0.0001754129,0.00009254505,0.00001915888,0.00002059331,0.0001953615,0.000003070017],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960662,0.001143569,0.00002681576,0.0002967958,0.0000397587,0.000006365439,0.0008764022,0.000003471877,0.001540602],"genre_scores_gemma":[0.9983656,0.0003699976,0.00001963174,0.0001424688,0.00005529864,0.000005003213,0.0006965614,0.000001155964,0.0003441732],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01464092,"threshold_uncertainty_score":0.02911144,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0177650252700915,"score_gpt":0.2572102415304075,"score_spread":0.239445216260316,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}